Vanguard Fiduciary Trust
TELO icon

Vanguard Fiduciary Trust’s Telomir Pharmaceuticals TELO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
225,304
+89,763
+66% +$117K ﹤0.01% 3460
2026
Q1 		$176K Buy
+135,541
New +$173K ﹤0.01% 3554

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

Vanguard Fiduciary Trust's TELO Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Telomir Pharmaceuticals (TELO) stake by 66% in Q2 2026, buying an estimated $117K and bringing the position to 225,304 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #3460.

Vanguard Fiduciary Trust first reported a position in TELO in Q1 2026 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • Vanguard Fiduciary Trust held 225,304 shares of Telomir Pharmaceuticals worth $288K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 89,763 Telomir Pharmaceuticals shares in Q2 2026, an estimated $117K.
  • Telomir Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3460 holding.
  • Vanguard Fiduciary Trust first reported a position in Telomir Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.